Sonoma Pharmaceuticals: Gains on strong Q2 results
** Healthcare company's shares SNOA.O rise 13.1% to a
one-week high of $7.5 in premarket trading
** Co reports second-quarter profit of 7 cents/shr, compared
with a loss of 98 cents/shr a year earlier urn:newsml:reuters.com:*:nBw8lCbP7a
** Posts 22% jump in quarterly revenue to $5.8 mln
** Up to Friday's close, stock has gained nearly 52% this
year
(Reporting by Shashank Nayar in Bengaluru)
((Shashank.Nayar@thomsonreuters.com; within U.S. +1 646 223
8780; outside U.S. +91 80 6182 2256;))
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing